Comphya, a Swiss medical device company, is developing the first implantable neurostimulator to treat erectile dysfunction (ED). The device, CaverSTIM, aims to…
Praxis is pleased to participate in this year’s in-person conference, sharing the latest research and developments from the Institute and our partners…
Praxis Spinal Cord Institute appoints four new members to the board of directors, bringing experience in finance, governance, community, and health care…
Praxis CEO, Bill Barrable and Director of Commercialization, Arushi Raina recently sat down with multi-awarded global visionary and frequent Forbes contributor, Stephen…